EDUCATION BACKGROUND

1 Post-doctoral training: Aug, 2012-Aug, 2013, major in nano-medicine, Medical Research Center of Cornell University, USA

2 Doctor Degree：Sep, 2008-- July, 2011, major in oncology, Tianjin Medical University&Tianjin, China.

3 Master Degree：Sep, 2003--July, 2006, major in cancer molecular biology, Tianjin Medical University&Tianjin, China.

4 Bachelor's Degree：Sep, 1998--July,2003, major in Clinical Medicine, Tianjin Medical University&Tianjin, China

PUBLICATIONS

1. Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer. Clinical Chemistry. 2014, 60 (1):233-242. Co-first author

2. MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein. J Biol Chem. 2017 Mar 3; 292(9):3614-3623. Co- correspondence 

3. Role of Carboxypeptidase N Invasion and Migration in Breast Cancer. Anticancer Agents Med Chem. 2016; 16(9):1198-202. Correspondence

FOUNDATIONS

1. Preside the National Natural Science Foundation

    Name：The molecular mechanism of the potential marker of liver cancer CCL15 on

the invasion and metastasis mediated by hepatitis X protein and its clinical detection value

    No. 81871719

RESEARCH ORIENTATION

  Screening the tumor markers of liver cancer metastasis and analyzing their functions.